Biologics US 2025: Bringing Biopharma Breakthroughs to life Join us, as Biologics US 2025 gathers North America’s biopharma leaders to tackle challenges in antibody and ADC R&D. See how experts are using AI-assisted design, novel protein targets, and advanced conjugation strategies to drive effective therapeutics. Don’t miss keynotes from Steve Turner and Ray Deshaies, GLIMPSE-1 human-first antibody insights from Wyatt McDonnell, and our Innovations & Breakthroughs Under the Stars Garden Party.